Authors

• Paul Richardson (ORCID: https://orcid.org/0000-0002-3700-8749)
• Melissa A. Ashley
• Dauzhan Yerkozhanov (ORCID: https://orcid.org/0009-0009-7552-171X)
• Balaram S. Takale (ORCID: https://orcid.org/0000-0001-8279-944X)
• Oliver D. Engl
• Zhen Lei (ORCID: https://orcid.org/0000-0002-6608-7933)
• George Karageorgis (ORCID: https://orcid.org/0000-0001-5088-6047)
• Johnny W. Lee (ORCID: https://orcid.org/0000-0002-0950-7815)
• Jan Pawlas (ORCID: https://orcid.org/0000-0002-8151-4112)
• Samuel C. Scott (ORCID: https://orcid.org/0000-0002-7338-3634)
• Vanessa Harawa (ORCID: https://orcid.org/0000-0001-9256-0846)
• Alan Steven (ORCID: https://orcid.org/0000-0002-0134-0918)
• Miles H. Aukland (ORCID: https://orcid.org/0000-0001-5141-4738)
• Christopher B. Kelly (ORCID: https://orcid.org/0000-0002-5530-8606)
• Pascal S. Engl (ORCID: https://orcid.org/0009-0002-7432-1301)
• Marian C. Bryan (ORCID: https://orcid.org/0000-0002-3138-6888)
• Alexandre Leclair (ORCID: https://orcid.org/0000-0002-6272-0527)
• Mingshuo Zeng (ORCID: https://orcid.org/0000-0003-1082-1227)
• Theresa Dutschei (ORCID: https://orcid.org/0000-0003-3053-9536)
• Megan A. Cismesia (ORCID: https://orcid.org/0000-0001-8639-2305)
• Wei Li
• Álvaro Enriquez Garcia

Institutions

• Roche (Switzerland) (CH)
• Novartis (Switzerland) (CH)
• Biogen (United States) (US)
• Johnson & Johnson (United States) (US)
• Pfizer (United States) (US)
• Age UK (GB)
• Northpoint Bible College (US)
• Novartis (China) (CN)
• Corteva (United States) (US)
• Eli Lilly (Spain) (ES)
• AstraZeneca (Poland) (PL)
• Oncopeptides (Sweden) (SE)
• Boehringer Ingelheim (United States) (US)
• Neurocrine Biosciences (United States) (US)
• Cardiff University (GB)

Publication Details

Journal

Organic Process Research & Development

Published

2024-09-10

DOI

https://doi.org/10.1021/acs.oprd.4c00300

Citations

4

Primary Topic

Chemistry and Chemical Engineering

Type

article

Field-Weighted Citation Impact

1.00